Is Medifast (MED) a great pick from the value investor's perspective right now? Read on to know more.
Jeffrey Brown, Insider at Medifast (NYSE:MED), made a large insider buy on November 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Brown purchased 4,200 shares of Medifast at at prices ranging from $218.49 to $235.28. The total transaction amounted to $973,911. Brown now owns a total of 34,957 of Medifast worth, 8,002,188. Medifast shares are trading up 2.77% at $228.92 at the time of this writing on Thursda
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. CommScope The Trade: Com